BioMarin Pharmaceutical Inc (BMRN) Social Stream
BIOMARIN PHARMACEUTICAL INC (BMRN) Price Targets From Analysts
Use the tables below to see what analysts covering BIOMARIN PHARMACEUTICAL INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 15 | $152 | $82 | $108.642 | $91.67 | 18.51% |
| 2021-11-15 | 15 | $152 | $82 | $108.928 | $91.67 | 18.83% |
| 2021-11-22 | 15 | $152 | $82 | $109.357 | $91.67 | 19.29% |
| 2022-01-05 | 15 | $155 | $88 | $111.5 | $91.67 | 21.63% |
| 2022-01-06 | 15 | $155 | $88 | $112.214 | $91.67 | 22.41% |
| 2022-01-21 | 15 | $155 | $88 | $112.571 | $91.67 | 22.8% |
| 2022-02-25 | 15 | $155 | $88 | $112.857 | $91.67 | 23.11% |
| 2022-02-28 | 13 | $155 | $88 | $115.75 | $91.67 | 26.27% |
| 2022-04-22 | 13 | $155 | $88 | $116.25 | $91.67 | 26.81% |
| 2022-04-26 | 13 | $155 | $88 | $117.666 | $91.67 | 28.36% |
| 2022-06-01 | 13 | $147 | $88 | $116.833 | $91.67 | 27.45% |
| 2022-06-21 | 13 | $136 | $70 | $110.416 | $91.67 | 20.45% |
| 2022-07-22 | 14 | $140 | $70 | $111.23 | $91.67 | 21.34% |
| 2022-08-02 | 13 | $140 | $70 | $113.166 | $91.67 | 23.45% |
| 2022-08-03 | 13 | $140.001 | $70 | $113.166 | $91.67 | 23.45% |
| 2022-08-05 | 14 | $140.001 | $70 | $114.769 | $91.67 | 25.2% |
| 2022-08-13 | 14 | $140.001 | $70 | $115 | $91.67 | 25.45% |
| 2022-09-27 | 14 | $140.001 | $74 | $115.384 | $91.67 | 25.87% |
| 2022-10-12 | 14 | $140.001 | $74 | $115.769 | $91.67 | 26.29% |
| 2022-10-21 | 15 | $140.001 | $74 | $113.857 | $91.67 | 24.2% |
| 2022-10-28 | 15 | $135 | $74 | $111.857 | $91.67 | 22.02% |
| 2022-11-23 | 15 | $135 | $74 | $113.142 | $91.67 | 23.42% |
| 2022-11-30 | 15 | $135 | $74 | $114.571 | $91.67 | 24.98% |
| 2023-01-04 | 15 | $135 | $74 | $115.285 | $91.67 | 25.76% |
| 2023-01-10 | 15 | $200 | $74 | $121.142 | $91.67 | 32.15% |
| 2023-01-13 | 15 | $200 | $83 | $121.785 | $91.67 | 32.85% |
| 2023-01-23 | 15 | $200 | $83 | $122.142 | $91.67 | 33.24% |
| 2023-01-27 | 15 | $200 | $83 | $123.5 | $91.67 | 34.72% |
| 2023-01-31 | 16 | $200 | $83 | $122.4 | $91.67 | 33.52% |
| 2023-02-08 | 16 | $200 | $83 | $122.933 | $91.67 | 34.1% |
| 2023-02-21 | 17 | $200 | $83 | $123.333 | $91.67 | 34.54% |
| 2023-02-27 | 17 | $200 | $83 | $123.333 | $91.67 | 34.54% |
| 2023-02-28 | 19 | $200 | $83 | $123.75 | $91.67 | 35% |
| 2023-03-07 | 19 | $200 | $74 | $123.176 | $91.67 | 34.37% |
| 2023-03-10 | 19 | $200 | $74 | $122.588 | $91.67 | 33.73% |
The Trend in the Analyst Price Target
BMRN's average price target has moved up $1.55 over the prior 34 months.
BMRN reports an average of 27.91% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-05 | 14 | 140.001 | 70 | 114.769 | 95.82 | 19.78% |
| 2022-10-31 | 15 | 135.000 | 74 | 113.142 | 86.63 | 30.6% |
| 2022-11-30 | 15 | 135.000 | 74 | 114.571 | 100.98 | 13.46% |
| 2023-01-04 | 15 | 135.000 | 74 | 115.285 | 106.92 | 7.82% |
| 2023-03-03 | 19 | 200.000 | 74 | 123.176 | 101.20 | 21.72% |
BMRN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.63 | 13 | 0 | 6 | 0 | 0 | 19 |
The Trend in the Broker Recommendations
Over the past 34 months, BMRN's average broker recommendation rating worsened by 0.19.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how BIOMARIN PHARMACEUTICAL INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 3615.88% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, BIOMARIN PHARMACEUTICAL INC's average analyst price target is higher than 3843.28% of them.
- In terms of how BIOMARIN PHARMACEUTICAL INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 741.44% of that group.
- To contextualize these metrics, consider that out of stocks in the large market cap category, BIOMARIN PHARMACEUTICAL INC's variance in analysts' estimates is lower than -3140.31% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to BIOMARIN PHARMACEUTICAL INC are NKTR, BHC, and VRTX.
View All Top Stocks by Price Target
What is the outlook for BMRN? Use POWR Ratings for clearer insight into price direction.